Current role
Biotechnology · Healthcare
Board Member
2025-11-24–present
Lee Scott Golden, M.D.
Board Member
Cadrenal Therapeutics, Inc. (CVKD)Equibles does not estimate personal net worth.
Get an email with a short summary when Cadrenal Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CVKD alertsAbout Lee Scott Golden, M.D.
Lee Scott Golden, M.D. is recorded as Board Member at Cadrenal Therapeutics, Inc. (CVKD) since November 24, 2025. Cadrenal Therapeutics, Inc. reported in an 8-K filed December 1, 2025 that Lee Scott Golden, M.D. was appointed Class II director, effective November 24, 2025. Cadrenal Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cadrenal Therapeutics, Inc. includes John P. Sharp (CFO), Matthew K. Szot (CFO), Quang X. Pham (CFO, Chief Accounting Officer and Board Member) and 7 others.
“On November 24, 2025, the Board of Directors (the “Board”) of Cadrenal Therapeutics, Inc. (the “Company”) appointed Lee Scott Golden, M.D. (“Dr. Golden”), to serve as a Class II director of the Company to hold office until the 2027 annual meeting of stockholders, at which time his term of office shall expire and a Class II director shall be elected for a full term of three years, or until his re-election or earlier resignation or removal.”
Affiliation history
-
Current
2025-11-24–present
Company network
Leadership on record at Cadrenal Therapeutics, Inc.
- John P. Sharp CFO
- Matthew K. Szot CFO
- Quang X. Pham CFO, Chief Accounting Officer, Board Member
- Jeffrey Cole COO
- Class I Directors Board Member
- Glynn Wilson Board Member
- John Murphy Board Member
- Lee Golden Board Member
- Robert Lisicki Board Member
- Steven Zelenkofske Board Member